Australia markets open in 21 minutes
  • ALL ORDS

    7,357.70
    -23.40 (-0.32%)
     
  • AUD/USD

    0.6916
    +0.0001 (+0.01%)
     
  • ASX 200

    7,112.80
    -14.90 (-0.21%)
     
  • OIL

    90.73
    +0.23 (+0.25%)
     
  • GOLD

    1,771.50
    +0.30 (+0.02%)
     
  • BTC-AUD

    33,650.90
    -341.27 (-1.00%)
     
  • CMC Crypto 200

    558.74
    +1.01 (+0.18%)
     

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

·6-min read
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting